ARTICLE | Company News
GPC Biotech and Bayer in antibacterials
August 14, 2000 7:00 AM UTC
GPC (NMarkt:GPC) will use its Reverse Genomics technology to conduct mode of action analyses on up to 50 antibacterial candidate compounds from Bayer (DAX:BAYG). BAYG will use the data to prioritize c...